BIOMARQUEURS POUR LA RÉPONSE AU TRAITEMENT DU PSORIASIS

• 收藏
• 分享

专利权人:

MERCK SHARP & DOHME CORP.

发明人:

MCELWEE, JOSHUA,MOGG, ROBIN,MEHROTRA, DEVAN

申请号：

EP13864159

公开号：

EP2935626A4

申请日:

2013.12.19

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Single nucleotide polymorphisms (SNPs) are provided that correlate with responsiveness of psoriasis patients to treatment with a therapeutic antibody that specifically binds to the p19 subunit of IL-23. The SNPs are used as biomarkers to prospectively selecting psoriasis patients likely to benefit from treatment with antagonists of IL-23, such as an antibody that specifically binds to the p19 subunit of IL-23.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/